American International Group, Inc. Astrazeneca PLC Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $33,322 - $37,985	-546 Reduced 1.35%	39,918 $2.7 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $47,964 - $53,692	775 Added 1.95%	40,464 $2.73 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $505,376 - $558,758	7,793 Added 24.43%	39,689 $2.69 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $39,359 - $42,681	-563 Reduced 1.73%	31,896 $2.28 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $23,554 - $26,706	-373 Reduced 1.14%	32,459 $2.25 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $189,680 - $246,469	-3,499 Reduced 9.63%	32,832 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $54,292 - $139,008	1,024 Added 2.9%	36,331 $1.99 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $35,259 - $42,328	595 Added 1.71%	35,307 $2.33 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1.93 Million - $2.33 Million	34,712 New	34,712 $2.3 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.